Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Change in Accured Expenses: 2021-2022

Historic Change in Accured Expenses for Milestone Pharmaceuticals (MIST) over the last 2 years, with Dec 2022 value amounting to -$391,000.

  • Milestone Pharmaceuticals' Change in Accured Expenses fell 140.81% to -$391,000 in Q4 2022 from the same period last year, while for Dec 2022 it was -$907,000, marking a year-over-year decrease of 242.39%. This contributed to the annual value of $875,000 for FY2024, which is 15.54% down from last year.
  • As of Q4 2022, Milestone Pharmaceuticals' Change in Accured Expenses stood at -$391,000, which was down 120.07% from $1.9 million recorded in Q3 2022.
  • In the past 5 years, Milestone Pharmaceuticals' Change in Accured Expenses ranged from a high of $1.9 million in Q3 2022 and a low of -$2.1 million during Q1 2022.
  • Over the past 2 years, Milestone Pharmaceuticals' median Change in Accured Expenses value was -$337,500 (recorded in 2021), while the average stood at -$33,750.
  • Within the past 5 years, the most significant YoY rise in Milestone Pharmaceuticals' Change in Accured Expenses was 271.76% (2022), while the steepest drop was 511.14% (2022).
  • Quarterly analysis of 2 years shows Milestone Pharmaceuticals' Change in Accured Expenses stood at $958,000 in 2021, then tumbled by 140.81% to -$391,000 in 2022.
  • Its Change in Accured Expenses stands at -$391,000 for Q4 2022, versus $1.9 million for Q3 2022 and -$325,000 for Q2 2022.